|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"jen chung ko"
Showing items 21-30 of 61 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells
|
Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.; JEN-CHUNG KO; Chen, J.-C.; Yen, T.-C.; Chen, T.-Y.; Ma, P.-F.; Lin, Y.-C.; Cheng, H.-H.; Taso, Y.-C.; Lin, Y.-W.;JEN-CHUNG KO |
| 臺大學術典藏 |
2019-12-18T06:15:22Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO; Wei, Yu-Feng; Huang, Wen-Tsung; Liu, Tu-Chen; Shieh, Jiunn-Min; Chian, Chih-Feng; Wu, Ming-Fang; Chang, Chih-Cheng; Lin, Ching-Hsiung; Lin, Chia-Mo; Hsia, Te-Chun |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-12-18T06:15:21Z |
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study
|
MENG RUI LEE;Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan;HUNG YANG KUO;KAI LUN YU;JEN-CHUNG KO; JEN-CHUNG KO; KAI LUN YU; HUNG YANG KUO; Liu, Tsung-Hao; Tsai, Jaw-Shiun; Wang, Jann-Yuan; MENG RUI LEE |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-09-16T09:25:32Z |
Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study
|
JEN-CHUNG KO;Liu, Tu Chen;Hsia, Te Chun;Lin, Ching Hsiung;Chang, Chih Cheng;Wei, Yu Feng;Wu, Ming Fang;Chian, Chih Feng;Lin, Chia Mo;Shieh, Jiunn Min;Huang, Wen Tsung; Huang, Wen Tsung; Shieh, Jiunn Min; Lin, Chia Mo; Chian, Chih Feng; Wu, Ming Fang; Wei, Yu Feng; Chang, Chih Cheng; Lin, Ching Hsiung; Hsia, Te Chun; Liu, Tu Chen; JEN-CHUNG KO |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T08:06:47Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
|
Sheng-Kai Liang;Meng-Rui Lee;Wei-Yu Liao;Chao-Chi Ho;Jen-Chung Ko;Jin-Yuan Shih; SHENG-KAI LIANG; MENG-RUI LEE; WEI-YU LIAO; CHAO-CHI HO; JEN-CHUNG KO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2018-09-10T18:07:07Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang, S.-K. and Lee, M.-R. and Liao, W.-Y. and Ho, C.-C. and Ko, J.-C. and Shih, J.-Y.; MENG RUI LEE; Wei-Yu Liao; Chao-Chi Ho; Jin-Yuan Shih; JEN-CHUNG KO; SHENG-KAI LIANG |
| 臺大學術典藏 |
2018-09-10T18:06:04Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang, S.-K. and Hsieh, M.-S. and Lee, M.-R. and Keng, L.-T. and Ko, J.-C. and Shih, J.-Y.; MENG-RUI LEE; KENG LI-TA; JEN-CHUNG KO; SHENG-KAI LIANG; JIN-YUAN SHIH |
Showing items 21-30 of 61 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
